At 9.1% CAGR, the Asia-Pacific Surgical Stapling Devices Market is projected to be worth US$ 1,657.88 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Asia-Pacific surgical stapling devices market was valued at US$ 985.06 million in 2022 and is expected to reach US$ 1,657.88 million by 2028, registering an annual growth rate of 9.1% from 2022 to 2028. Increasing popularity of cosmetic surgery and medical tourism in developing economies and technological advancement are the critical factors attributed to the Asia-Pacific surgical stapling devices market expansion.

The beauty industry and standards have undergone a significant change in the last few decades. People are not thinking twice before opting for cosmetic procedures to keep up with beauty standards. In addition to surgeries performed for enhancing aesthetics, the demand for various procedures such as breast augmentation, tummy tuck, lipoplasty, rhinoplasty, and hair transplant is increasing significantly. In the past few years, there has been significant growth in breast augmentation and implant removal procedures. Therefore, a surge in the popularity of cosmetic surgeries and the growth of medical tourism in developing economies are creating ample opportunities for the surgical stapling devices market players.

On the contrary, increase in product recalls and high cost of surgical stapling devices hurdles the growth of Asia-Pacific surgical stapling devices market.    

Based on product, the Asia-Pacific surgical stapling devices market is segmented into powered surgical staplers and manual surgical staplers. The powered surgical staplers segment held 57.4% market share in 2022, amassing US$ 565.49 million. It is projected to garner US$ 982.33 million by 2028 to expand at 9.6% CAGR during 2022–2028.  

Based on type, the Asia-Pacific surgical stapling devices market is segmented into disposable surgical staplers and reusable surgical staplers. The disposable surgical staplers segment held 61.6% market share in 2022, amassing US$ 607.09 million. It is projected to garner US$ 1,039.56 million by 2028 to expand at 9.4% CAGR during 2022–2028.

Based on application, the Asia-Pacific surgical stapling devices market is segmented into orthopedic surgery, endoscopic surgery, cardiac and thoracic surgery, abdominal and pelvic surgery, and others. The orthopedic surgery segment held 33.9% market share in 2022, amassing US$ 333.60 million. It is projected to garner US$ 592.71 million by 2028 to expand at 10.1% CAGR during 2022–2028.

Based on end user, the Asia-Pacific surgical stapling devices market is segmented into hospitals and ambulatory surgical centers. The hospitals segment held 70.8% market share in 2022, amassing US$ 697.63 million. It is projected to garner US$ 1,191.23 million by 2028 to expand at 9.3% CAGR during 2022–2028.

Based on country, the Asia-Pacific surgical stapling devices market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific. Our regional analysis states that China captured 27.6% market share in 2022. It was assessed at US$ 271.91 million in 2022 and is likely to hit US$ 482.28 million by 2028, exhibiting a CAGR of 10.0% during the forecast period.    

Key players dominating the Asia-Pacific surgical stapling devices market are 3M Co, B. Braun SE, Conmed Corp, Ethicon USA LLC, Frankenman International Ltd, Intutive Surgical Inc, Medtronic Plc, and Panther Healthcare Medical Equipment Co Ltd among others.  

• In Dec 2021, Intutive Surgical Inc received FDA clearance for 8 mm SureForm 30 Curved-Tip Stapler. and reloads for use in general, thoracic, gynecologic, urologic, and pediatric surgery.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com